Arteparon

Arteparon: description of the drug and its use

Arteparon is a medication used to treat diseases of the musculoskeletal system. The drug is produced by the pharmaceutical company Luitpold Pharma GmbH in Germany and belongs to the group of biogenic agents.

The international name of the drug is Mukarthrin, and its synonyms are also used in medical practice. Arteparon is available as an injection solution containing 50 mg of the active substance - mucopolysaccharide sulfuric acid ester.

Indications for the use of Arteparon include the following diseases of the musculoskeletal system: arthrosis of the hip, knee and small joints, degenerative diseases of the spine, degenerative changes in the cartilage of the patella, subsequent treatment after removal of the meniscus, as well as limited mobility in the shoulder joint.

Contraindications to the use of Arteparon include an increased risk of bleeding and hemorrhagic diathesis. When using the drug, side effects may occur, such as sensitization, headache, perspiration, nausea, tachycardia and shortness of breath. However, these phenomena usually do not pose a serious threat to health and only require discontinuation of the drug. Thromboembolic processes are also possible as a consequence of increased platelet aggregation of immunological origin.

Cross-sensitization with heparin and heparinoids has been noted. In rare cases, skin hemorrhage and bleeding from the mucous membranes are possible. When using Arteparon, simultaneous use with heparin and heparinoids should be avoided to avoid the risk of bleeding.

There is no data on overdose of Arteparon, and there are no special instructions for the use of the drug.

In general, Arteparon is an effective and safe drug for the treatment of diseases of the musculoskeletal system. However, like any other medication, it should be used only after a doctor's prescription and in accordance with the recommended dosage.